Pharmaceutical Stocks To Consider - July 24th

Thermo Fisher Scientific, Honeywell International, Eli Lilly and Company, D-Wave Quantum, and IQVIA are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture and sell prescription drugs and medical therapies. Investors who buy these stocks gain partial ownership in firms whose value is driven by factors such as clinical trial results, regulatory approvals, patent lifecycles and product pipelines. Performance can be volatile, reflecting both scientific breakthroughs and regulatory or competitive risks. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of NYSE:TMO traded up $13.02 on Thursday, hitting $479.73. 4,174,449 shares of the company's stock were exchanged, compared to its average volume of 2,484,647. Thermo Fisher Scientific has a 12 month low of $385.46 and a 12 month high of $627.88. The stock has a market capitalization of $181.10 billion, a price-to-earnings ratio of 28.10, a price-to-earnings-growth ratio of 2.06 and a beta of 0.77. The business's 50 day simple moving average is $411.01 and its two-hundred day simple moving average is $471.10. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.77 and a quick ratio of 1.38.

Read Our Latest Research Report on TMO

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company's Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

Shares of NASDAQ:HON traded down $11.79 on Thursday, hitting $227.48. 6,740,784 shares of the company's stock were exchanged, compared to its average volume of 4,103,929. The stock has a market capitalization of $146.20 billion, a price-to-earnings ratio of 26.11, a price-to-earnings-growth ratio of 2.69 and a beta of 1.07. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.25 and a quick ratio of 0.95. Honeywell International has a 12 month low of $179.36 and a 12 month high of $242.77. The business's 50 day simple moving average is $229.34 and its two-hundred day simple moving average is $216.95.

Read Our Latest Research Report on HON

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of Eli Lilly and Company stock traded up $7.96 during trading on Thursday, hitting $806.85. 1,562,250 shares of the stock traded hands, compared to its average volume of 3,764,686. The stock's fifty day simple moving average is $769.41 and its 200 day simple moving average is $799.86. Eli Lilly and Company has a 52-week low of $677.09 and a 52-week high of $972.53. The company has a current ratio of 1.37, a quick ratio of 1.06 and a debt-to-equity ratio of 2.18. The firm has a market cap of $764.68 billion, a P/E ratio of 65.58, a price-to-earnings-growth ratio of 1.12 and a beta of 0.40.

Read Our Latest Research Report on LLY

D-Wave Quantum (QBTS)

D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Ocean, a suite of open-source python tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community.

Shares of QBTS stock traded down $0.38 during trading hours on Thursday, reaching $19.93. 35,435,005 shares of the company's stock were exchanged, compared to its average volume of 71,450,570. D-Wave Quantum has a 1 year low of $0.75 and a 1 year high of $20.56. The stock has a market cap of $5.82 billion, a PE ratio of -33.22 and a beta of 1.40. The company has a current ratio of 20.73, a quick ratio of 20.61 and a debt-to-equity ratio of 0.15. The stock's fifty day moving average price is $16.32 and its two-hundred day moving average price is $10.16.

Read Our Latest Research Report on QBTS

IQVIA (IQV)

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Shares of IQVIA stock traded up $8.75 on Thursday, reaching $202.99. 3,184,036 shares of the stock were exchanged, compared to its average volume of 2,025,721. The company has a quick ratio of 0.82, a current ratio of 0.84 and a debt-to-equity ratio of 2.45. IQVIA has a twelve month low of $134.65 and a twelve month high of $252.88. The firm has a market capitalization of $35.12 billion, a price-to-earnings ratio of 29.34, a PEG ratio of 2.21 and a beta of 1.30. The business has a 50 day moving average price of $154.75 and a two-hundred day moving average price of $170.52.

Read Our Latest Research Report on IQV

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.